07:00 , Jun 4, 2009 |  BC Innovations  |  Distillery Therapeutics

This week in therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Renal disease Cystatin C (CST3); CST9; glycine amidinotransferase (GATM); shroom family member 3 (SHROOM3); spermatogenesis associated 5-like 1 (SPATA5L1); uromodulin...